Redwire Corp (RDW) said Monday it has expanded its in-space drug development program by launching a new drug development technology and a cancer-detection experiment to the International Space Station.
The company launched an industrial crystallizer to process more enhanced samples that could be previously processed in the original PIL-BOX technology, Redwire added.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。